[Skip to Content]

Dorzolomide hydrochloride

Class 2 Medicines Recall (action within 48 hours): COSOPT Preservative-Free, 20mg/ml +5mg/ml, eye drops, solution, single-dose container – Merck Sharp & Dohme Limited (EL (14)A/02)

Merck Sharp & Dohme Limited COSOPT Preservative-Free, 20mg/ml +5mg/ml, eye drops, solution, single-dose container (Dorzolamide / Timolol) PL 00025/0698 Batch number Expiry Date Pack size First distributed MK13D002 30 April 2015 60 single dose containers 9 September 2013 MK13D004 30 April 2015 60 single dose containers 4 July 2013 Merck Sharp and Dohme is recalling

MHRA Drug Safety Alert: Dorzolomide hydrochloride/timolol maleate (Cosopt) preservative-free single-dose eye drops: reports of eye injury

Dorzolomide hydrochloride/timolol maleate (Cosopt) preservative-free single-dose eye drops are used to treat glaucoma. The MHRA is aware of 69 complaints in the UK with this product after the introduction of a new design of dropper in July 2013. These reports include scratches to the cornea, and difficulty in administration of the drops onto the eye.